Amgen Statistics
Share Statistics
Amgen has 537.53M shares outstanding. The number of shares has increased by 0.3% in one year.
| Shares Outstanding | 537.53M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 536.25M |
| Failed to Deliver (FTD) Shares | 2.09K |
| FTD / Avg. Volume | 0.06% |
Short Selling Information
The latest short interest is 11.53M, so 2.15% of the outstanding shares have been sold short.
| Short Interest | 11.53M |
| Short % of Shares Out | 2.15% |
| Short % of Float | 2.15% |
| Short Ratio (days to cover) | 2.55 |
Valuation Ratios
The PE ratio is 22.94 and the forward PE ratio is 14.46. Amgen 's PEG ratio is 0.38.
| PE Ratio | 22.94 |
| Forward PE | 14.46 |
| PS Ratio | 5.47 |
| Forward PS | 4 |
| PB Ratio | 24.73 |
| P/FCF Ratio | 20.94 |
| PEG Ratio | 0.38 |
Enterprise Valuation
Amgen Inc. has an Enterprise Value (EV) of 207.76B.
| EV / Earnings | 30.93 |
| EV / Sales | 7.37 |
| EV / EBITDA | 14.13 |
| EV / EBIT | 26.31 |
| EV / FCF | 28.23 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 10.37.
| Current Ratio | 1.65 |
| Quick Ratio | 1.13 |
| Debt / Equity | 10.37 |
| Total Debt / Capitalization | 91.2 |
| Cash Flow / Debt | 0.13 |
| Interest Coverage | 2.75 |
Financial Efficiency
Return on equity (ROE) is 1.08% and return on capital (ROIC) is 9.53%.
| Return on Equity (ROE) | 1.08% |
| Return on Assets (ROA) | 0.07% |
| Return on Capital (ROIC) | 9.53% |
| Revenue Per Employee | 1.06M |
| Profits Per Employee | 251.57K |
| Employee Count | 26.70K |
| Asset Turnover | 0.29 |
| Inventory Turnover | 0.88 |
Taxes
| Income Tax | 1.14B |
| Effective Tax Rate | 0.14 |
Stock Price Statistics
The stock price has increased by -13.81% in the last 52 weeks. The beta is 0.6, so Amgen 's price volatility has been higher than the market average.
| Beta | 0.6 |
| 52-Week Price Change | -13.81% |
| 50-Day Moving Average | 287.48 |
| 200-Day Moving Average | 304.56 |
| Relative Strength Index (RSI) | 34.05 |
| Average Volume (20 Days) | 3.24M |
Income Statement
In the last 12 months, Amgen had revenue of 28.19B and earned 6.72B in profits. Earnings per share was 12.56.
| Revenue | 28.19B |
| Gross Profit | 19.77B |
| Operating Income | 7.90B |
| Net Income | 6.72B |
| EBITDA | 14.70B |
| EBIT | 7.90B |
| Earnings Per Share (EPS) | 12.56 |
Balance Sheet
The company has 10.94B in cash and 64.61B in debt, giving a net cash position of -53.67B.
| Cash & Cash Equivalents | 10.94B |
| Total Debt | 64.61B |
| Net Cash | -53.67B |
| Retained Earnings | -26.55B |
| Total Assets | 90.88B |
| Working Capital | 6.45B |
Cash Flow
In the last 12 months, operating cash flow was 8.47B and capital expenditures -1.11B, giving a free cash flow of 7.36B.
| Operating Cash Flow | 8.47B |
| Capital Expenditures | -1.11B |
| Free Cash Flow | 7.36B |
| FCF Per Share | 13.76 |
Margins
Gross margin is 7.01K%, with operating and profit margins of 2.80K% and 2.38K%.
| Gross Margin | 7.01K% |
| Operating Margin | 2.80K% |
| Pretax Margin | 2.79K% |
| Profit Margin | 2.38K% |
| EBITDA Margin | 52.15% |
| EBIT Margin | 28.01% |
| FCF Margin | 26.11% |
Dividends & Yields
AMGN pays an annual dividend of $9.52, which amounts to a dividend yield of 3.67%.
| Dividend Per Share | $9.52 |
| Dividend Yield | 3.67% |
| Dividend Growth (YoY) | 11.74% |
| Payout Ratio | 121.74% |
| Earnings Yield | 4.81% |
| FCF Yield | 5.24% |
Analyst Forecast
The average price target for AMGN is $335, which is 28.3% higher than the current price. The consensus rating is "Hold".
| Price Target | $335 |
| Price Target Difference | 28.3% |
| Analyst Consensus | Hold |
| Analyst Count | 23 |
Stock Splits
The last stock split was on Nov 22, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 22, 1999 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 1.34 |
| Piotroski F-Score | 6 |